Osteoarthritis News and Research

Latest Osteoarthritis News and Research

New imaging technology may serve as objective outcome measures for orthopedic conditions

New imaging technologies are enabling doctors to not only diagnose a variety of orthopaedic and musculoskeletal conditions with more accuracy, but also to determine with unprecedented precision whether clinical recovery from bone, joint or tendon damage is actually complete and not simply a "placebo effect."

27 Feb 2005

Lack of collagen increases likelihood of osteoarthritis

Duke University Medical Center researchers have found that joints whose cartilage lacks a specific type of collagen will develop osteoarthritis – the so-called "wear-and-tear" form of the disease – at a greatly accelerated rate.

20 Feb 2005

Merck issues statement on Vioxx lawsuits

The federal Judicial Panel on Multidistrict Litigation today granted motions by several parties, including Merck, to transfer all Vioxx product liability lawsuits pending in federal courts nationwide into one consolidated Multidistrict Litigation (MDL) for coordinated pre-trial proceedings.

16 Feb 2005

Paracetamol effective for chronic pain and arthritis

A research team from University of Queensland has just published the results of a small study into the effectiveness of medications for chronic pain.

27 Jan 2005

More studies on risks and benefits of COX-2 inhibitors

A group of studies published in the January 24 issue of Archives of Internal Medicine add to the growing body of medical literature about the cardiovascular risks that may be associated with the class of pain-relieving drugs known as COX-2 inhibitors.

24 Jan 2005

Strong association between high levels of hyaluronic acid and severe osteoarthritis

A chronic degenerative joint disease, osteoarthritis (OA) is a common cause of pain and disability among older Americans. OA of the knee affects up to 6 percent of the older population, while OA of the hip affects about another 3 percent. While treatments vary, there is hope that early intervention – before joint destruction can be clearly seen and measured on an X-ray image-will improve outcomes.

7 Jan 2005

Chronic users NSAIDs have greater risk of bleeding and visible damage to their small intestine

According to a study published today in the American Gastroenterological Association (AGA) journal Clinical Gastroenterology and Hepatology, chronic users of non-steroidal anti-inflammatory drugs (NSAIDs) have an increased risk of bleeding and visible damage to their small intestine.

4 Jan 2005

Signaling molecule involved in osteoarthritis identified

Using naturally-occurring mutant mice with a defective collagen gene, scientists at Harvard have identified a signaling molecule involved in one of the most common causes of disability among the elderly in the United States, osteoarthritis.

4 Jan 2005

Laser therapy may be considered by arthritis patients as a safe Vioxx alternative

Adverse events of long term medication with NSAIDs and particularly coxibs, has recently received much attention in the Vioxx matter. Consequently, Vioxx has been withdrawn and Prexige has been withheld from the market. The whole group of coxibs, are now under special observation by drug agencies in both Europe and the United States.

27 Dec 2004

Public health advisory for the use of non-steroidal anti-inflammatory drug products

The Food and Drug Administration (FDA) has issued a Public Health Advisory summarizing the agency's recent recommendations concerning the use of non-steroidal anti-inflammatory drug products (NSAIDs), including those known as COX-2 selective agents.

23 Dec 2004

Arthritis drug caution advised by New Zealand experts

An expert New Zealand committee reviewing the safety of a group of arthritis drugs called COX-2 inhibitors has reinforced UK advice cautioning against their routine use where safe and effective alternatives are available.

21 Dec 2004

No increased cardiovascular risk seen in elderly patients taking Celebrex

The National Institutes of Health has reported in an Alzheimer's Disease prevention study that there was no increased cardiovascular risk seen in elderly patients taking Celebrex (400 mg daily) for up to three years.

21 Dec 2004

ChondroGene and Pfizer osteoarthritis collaboration

ChondroGene reported today that it has entered into a new two-year research collaboration with Pfizer for the identification of novel therapeutic targets and biomarkers for the treatment and diagnosis of osteoarthritis (OA).

21 Dec 2004

New advice on anti-inflammatory drugs called Cox-2 Inhibitors, including Celebrex

Patients who are taking Celebrex, Bextra and Arcoxia should make a non-urgent appointment with their GP to review their treatment. Patients who have established heart disease or who are at high risk of stroke will have their treatment changed.

21 Dec 2004

5000 year old system of medicine provides pain relief for people with osteoarthritis of the knee

A 5000 year old system of medicine, acupuncture provides pain relief and improves function for people with osteoarthritis of the knee and serves as an effective complement to standard care.

20 Dec 2004

Magnetic bracelets reduce pain in osteoarthritis of the hip and knee

Osteoarthritis affects around 760,000 people in the United Kingdom, producing over 3 million general practice consultations in 2000. Manufacturers of magnetic bracelets claim that they can reduce pain and worldwide sales were estimated at £2.6bn ($5bn) in 1999. But evidence about their effectiveness is contradictory.

20 Dec 2004

Celebrex suspension

The National Institutes of Health (NIH) announced that it has suspended the use of COX-2 inhibitor celecoxib (Celebrex™ Pfizer, Inc.) for all participants in a large colorectal cancer prevention clinical trial conducted by the National Cancer Institute (NCI).

19 Dec 2004

Benefits of weight loss may depend on alignment of affected leg, study suggests

A painful and sometimes crippling disease characterized by progressive cartilage loss, osteoarthritis (OA) of the knee affects an estimated 6 percent of adults over age 30.

2 Dec 2004

Topical cream alternative to Vioxx

A clinical study recently published in The Journal of Rheumatology concludes that a topical cream consisting of a blend of natural oils called cetylated fatty acids significantly increased range of motion and physical performance in patients with osteoarthritis of the knee with no reported side effects.

24 Nov 2004

Patients with knee osteoarthritis should avoid long term use of non-steroidal anti-inflammatory drugs

Current guidelines recommend the use of oral NSAIDs in the treatment of knee osteoarthritis and they are used regularly by half of all patients with painful osteoarthritis.

23 Nov 2004

Osteoarthritis News and Research

Latest Osteoarthritis News and Research

New imaging technology may serve as objective outcome measures for orthopedic conditions

Lack of collagen increases likelihood of osteoarthritis

Merck issues statement on Vioxx lawsuits

Paracetamol effective for chronic pain and arthritis

More studies on risks and benefits of COX-2 inhibitors

Strong association between high levels of hyaluronic acid and severe osteoarthritis

Chronic users NSAIDs have greater risk of bleeding and visible damage to their small intestine

Signaling molecule involved in osteoarthritis identified

Laser therapy may be considered by arthritis patients as a safe Vioxx alternative

Public health advisory for the use of non-steroidal anti-inflammatory drug products

Arthritis drug caution advised by New Zealand experts

No increased cardiovascular risk seen in elderly patients taking Celebrex

ChondroGene and Pfizer osteoarthritis collaboration

New advice on anti-inflammatory drugs called Cox-2 Inhibitors, including Celebrex

5000 year old system of medicine provides pain relief for people with osteoarthritis of the knee

Magnetic bracelets reduce pain in osteoarthritis of the hip and knee

Celebrex suspension

Benefits of weight loss may depend on alignment of affected leg, study suggests

Topical cream alternative to Vioxx

Patients with knee osteoarthritis should avoid long term use of non-steroidal anti-inflammatory drugs

Realizing the Importance of Medical Electronic Devices

Everything about SpatialOMx

How the science of happiness is helping student mental health

Antibodies eBook

Osteoarthritis News and Research

Latest Osteoarthritis News and Research

Realizing the Importance of Medical Electronic Devices

Everything about SpatialOMx

How the science of happiness is helping student mental health

Antibodies eBook

Newsletters you may be interested in